Cargando…

Development of conversion therapy for advanced hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Matsuki, Ryota, Kogure, Masaharu, Hasui, Nobuhiro, Momose, Hirokazu, Suzuki, Yutaka, Sakamoto, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282663/ https://www.ncbi.nlm.nih.gov/pubmed/37351138 http://dx.doi.org/10.21037/hbsn-23-204

Ejemplares similares

Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression
por: Matsuki, Ryota, et al.
Publicado: (2022)

Bisegmentectomy and venous reconstruction after portal vein embolization for the remnant hemiliver in a patient with recurrent colorectal liver metastases
por: Matsuki, Ryota, et al.
Publicado: (2020)

A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer
por: Okano, Naohiro, et al.
Publicado: (2022)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2022)

In vitro ballooned hepatocytes can be produced by primary human hepatocytes and hepatic stellate cell sheets
por: Hasui, Nobuhiro, et al.
Publicado: (2022)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review
por: Zhang, Zunyi, et al.
Publicado: (2023)

Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
por: Hatanaka, Takeshi, et al.
Publicado: (2023)

Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2023)

Defining conversion therapy for esophageal squamous cell carcinoma
por: Matsuda, Satoru, et al.
Publicado: (2022)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
por: Ohya, Yuki, et al.
Publicado: (2020)

Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy
por: Zhang, Zunyi, et al.
Publicado: (2023)

Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

The advanced development of molecular targeted therapy for hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2022)

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy
por: Ho, Won Jin, et al.
Publicado: (2020)

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies
por: Guan, Yong-Song, et al.
Publicado: (2014)

Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022)

Recent Advances in Bioinformatics Reveal the Molecular Heterogeneity of Hepatocellular Carcinoma
Publicado: (2014)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
por: Zhao, Hai-Tao, et al.
Publicado: (2021)

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
por: Masuzaki, Ryota, et al.
Publicado: (2022)

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib
por: Yamaoka, Kenji, et al.
Publicado: (2021)

Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy
por: Xie, Qing-Yu, et al.
Publicado: (2022)

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

GLS2 shapes ferroptosis in hepatocellular carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2023)

Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study
por: Wang, Lijun, et al.
Publicado: (2023)

The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma
por: Bai, Jinfeng, et al.
Publicado: (2023)

Advanced Materials for Electrochemical Energy Conversion and Storage Devices
por: Santos, Diogo M. F., et al.
Publicado: (2021)

Advanced Photocatalytic Nanomaterials for Energy Conversion and Environmental Remediation
por: Zhang, Junying, et al.
Publicado: (2023)

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
por: Kim, Beom Kyung
Publicado: (2023)

Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
por: Khare, Tripti, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_857bbunh1c755ki3f867vcfegu